It was used to determine whether CSF TDP-43 could distinguish patients with ALS from those with Guillain-Barré syndrome (GBS), an inflammatory peripheral neuropathy that can also affect motor neurons [125]. This evidence concerns the gene TARDBP and Guillain-Barre syndrome.